Accelerator Nordic AB holds an active majority position in a number of companies active in the Life Science space.
The Accelerator Group addresses biotechnology, pharmaceutical drug development and medical technology in large growth markets such as medical imaging, oncology and drug delivery for orthopedic and dental implants.
21 December, 2011
SyntheticMR AB, a subsidiary of Accelerator Nordic AB, has recruited Stefan Tell as CEO.
21 December, 2011
Accelerator: SyntheticMR recruits Stefan Tell as CEO
12 December, 2011
Dr. Anders Jönsson appointed to AddBIO’s advisory board
30 November, 2011
Accelerator: SPAGO Imaging granted financing from VINNOVA
Feb 24, 2012
Quarterly report Jan-Dec 2011
Apr 25, 2012
Annual general meeting
Apr 25, 2012
Quarterly report Jan-Mar 2012
Watch the latest presentation of Accelerator by CEO Andreas Bunge
© 2010-2012 Accelerator Nordic AB. All rights reserved.
